Large gap with delayed quotes
|
Last quote
09/19/2026
-
02:00:00
|
Bid
09/21/2026 -
10:14:41
|
Bid Volume |
Ask
09/21/2026 -
10:14:41
|
Ask Volume |
|---|---|---|---|---|
|
784.85
-4.60
(
-0.58% )
|
760.29
|
80 |
869.70
|
40 |
Analysis date: 18.09.2026
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 18.09.2026.
Quality
Strong
Strong
Three stars since 18.09.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 31.07.2026 at a price of 762.63.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 07.07.2026.
4wk Rel Perf
-2.60%
-2.60%
The four-week dividend-adjusted underperformance versus SP500 is 2.60%.
Risk
Low
Low
The stock has been on the low-sensitivity level since 29.05.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.65%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.53%.
Mkt Cap in $bn
80.80
80.80
With a market capitalization >$8bn, REGENERON PHARMA is considered a large-cap stock.
G/PE Ratio
1.16
1.16
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
10.16
10.16
The estimated PE is for the year 2028.
LT Growth
11.31%
11.31%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
24
24
Over the last seven weeks, an average of 24 analysts provided earnings per share estimates.
Dividend Yield
0.51%
0.51%
The twelve month estimated dividend yield represents 5.21% of earnings forecasts.
Beta
38
38
For 1% of index variation, the stock varies on average by 0.38%.
Correlation
0.13
0.13
Stock movements are totally independent of index variations.
Value at Risk
89.06
89.06
The value at risk is estimated at USD 89.06. The risk is therefore 11.35%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.04.2004
02.04.2004